Global cancer drugs market is expected to grow with a CAGR of 7.2% over the forecast period from 2018-2024

Friday, December 14, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 13, 2018 /PRNewswire/ -- The report on the global cancer drugs market provides qualitative and quantitative analysis for the period from 2016 to 2024.

Read the full report: https://www.reportlinker.com/p05627415 The report predicts the global cancer drugs market to grow with a CAGR of 7.2% over the forecast period from 2018-2024. The study on cancer drugs market covers the analysis of the
leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.The report on the cancer drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cancer drugs market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cancer drugs market over the period of 2016 to 2024. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.Report Findings1) Drivers• Growing Occurrence of Different Types of Cancer• Increasing Concerns related High Death Rates due to Cancer• Advancement in Cancer Treatment Technology2) Restraints• High Cost of Cancer Treatments3) Opportunities• Introduction of Novel Cancer Drugs ProductsResearch MethodologyA) Primary ResearchOur primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include1. Key Opinion Leaders associated with Infinium Global Research2. Internal and External subject matter experts3. Professionals and participants from the industryOur primary research respondents typically include1. Executives working with leading companies in the market under review2. Product/brand/marketing managers3. CXO level executives4. Regional/zonal/ country managers5. Vice President level executives.B) Secondary ResearchSecondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.The secondary sources of the data typically include1. Company reports and publications2. Government/institutional publications3. Trade and associations journals4. Databases such as WTO, OECD, World Bank, and among others.5. Websites and publications by research agenciesSegment CoveredThe global cancer drugs market is segmented on the basis of types, and application.The Global Cancer Drugs Market by Types• Breast Cancer• Gastrointestinal Cancer• Blood Cancer• Bladder Cancer• Liver Cancer• Lung And Bronchus Cancer• Skin Cancer• OthersThe Global Cancer Drugs Market by Application• Immunotherapy• Targeted Therapy• Hormone Therapy• ChemotherapyCompany Profiles• Bayer AG• Eli Lilly and Company• Novartis AG• Amgen Inc.• GlaxoSmithKline Plc.• Bristol-Myers Squibb Company• Pfizer Inc• Merck & Co., Inc.• CELGENE CORPORATION• Boehringer Ingelheim International GmbH• SanofiWhat does this report deliver?1. Comprehensive analysis of the global as well as regional markets of the cancer drugs market.2. Complete coverage of all the segments in the cancer drugs market to analyze the trends, developments in the global market and forecast of market size up to 2024.3. Comprehensive analysis of the companies operating in the global cancer drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.Read the full report: https://www.reportlinker.com/p05627415 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/global-cancer-drugs-market-is-expected-to-grow-with-a-cagr-of-7-2-over-the-forecast-period-from-2018-2024--300765214.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store